Review



rabbit anti sars cov2 n protein antibody  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Sino Biological rabbit anti sars cov2 n protein antibody
    Rabbit Anti Sars Cov2 N Protein Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 97/100, based on 336 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti sars cov2 n protein antibody/product/Sino Biological
    Average 97 stars, based on 336 article reviews
    rabbit anti sars cov2 n protein antibody - by Bioz Stars, 2026-03
    97/100 stars

    Images



    Similar Products

    97
    Sino Biological rabbit anti sars cov2 n protein antibody
    Rabbit Anti Sars Cov2 N Protein Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti sars cov2 n protein antibody/product/Sino Biological
    Average 97 stars, based on 1 article reviews
    rabbit anti sars cov2 n protein antibody - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    90
    Jackson Immuno rabbit anti-sars-cov2 n protein polyclonal antibody
    Rabbit Anti Sars Cov2 N Protein Polyclonal Antibody, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-sars-cov2 n protein polyclonal antibody/product/Jackson Immuno
    Average 90 stars, based on 1 article reviews
    rabbit anti-sars-cov2 n protein polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Sino Biological rabbit polyclonal antibodies against sars cov2 n nucleocapsid proteins
    (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against <t>SARS-CoV2</t> N <t>nucleocapsid</t> proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.
    Rabbit Polyclonal Antibodies Against Sars Cov2 N Nucleocapsid Proteins, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against sars cov2 n nucleocapsid proteins/product/Sino Biological
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal antibodies against sars cov2 n nucleocapsid proteins - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    Sino Biological rabbit polyclonal antibodies against sars cov2 n nucleocapsid protein
    (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against <t>SARS-CoV2</t> N <t>nucleocapsid</t> proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.
    Rabbit Polyclonal Antibodies Against Sars Cov2 N Nucleocapsid Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies against sars cov2 n nucleocapsid protein/product/Sino Biological
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal antibodies against sars cov2 n nucleocapsid protein - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    96
    Sino Biological rabbit monoclonal antibody against sars cov2 n protein
    Distribution of <t> SARS-CoV2 </t> antigen in Brain. 4 brains were analyzed at 6dpi. + <++ <+++ Represents Relative density of antigen presence. - No antigen detected. (+) Represents presence of antigen in some samples only. AON-Anterior Olfactory Nucleus. Neuroanatomical Reference: ALLEN Brain Atlas. http://atlas.brain-map.org/atlas?atlas=2#atlas=2&plate=100883770&structure=168&x=7797.5&y=4023.9999997615814&zoom=−3&resolution=10.47&z=5 .
    Rabbit Monoclonal Antibody Against Sars Cov2 N Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal antibody against sars cov2 n protein/product/Sino Biological
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal antibody against sars cov2 n protein - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.

    Journal: PeerJ

    Article Title: A novel one-step quick assay for detection of SARS-COV2 antibodies across mammalian species

    doi: 10.7717/peerj.11381

    Figure Lengend Snippet: (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.

    Article Snippet: Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were purchased from SinoBiological (cat. 40588-T62).

    Techniques: Labeling, Fluorescence, Incubation, Negative Control, Positive Control

    (A) The positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein. The negative controls are 4 representative samples (SDBB1-4 (B–E)) from the 50 pre-pandemic human serum samples from San Diego Blood Bank (SDBB). Patient Group A has 20 SARS-CoV2 patient sera deemed positive (either IgG or IgM positive) by LFIA conducted by RayBiotech. All of the 20 patient samples are positive for anti-scN antibodies by the one-step test. (F–J) 5 representatives of the 20 positive samples are shown. Patient Group B has 20 SARS-CoV2 patient serum samples deemed negative (both IgG and IgM are negative) by LFIA conducted by RayBiotech. A total of 19 out of the 20 LFIA negative samples are positive for anti-scN antibodies by the one-step test. (K–O) 5 representatives of the 19 positive samples are shown.

    Journal: PeerJ

    Article Title: A novel one-step quick assay for detection of SARS-COV2 antibodies across mammalian species

    doi: 10.7717/peerj.11381

    Figure Lengend Snippet: (A) The positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein. The negative controls are 4 representative samples (SDBB1-4 (B–E)) from the 50 pre-pandemic human serum samples from San Diego Blood Bank (SDBB). Patient Group A has 20 SARS-CoV2 patient sera deemed positive (either IgG or IgM positive) by LFIA conducted by RayBiotech. All of the 20 patient samples are positive for anti-scN antibodies by the one-step test. (F–J) 5 representatives of the 20 positive samples are shown. Patient Group B has 20 SARS-CoV2 patient serum samples deemed negative (both IgG and IgM are negative) by LFIA conducted by RayBiotech. A total of 19 out of the 20 LFIA negative samples are positive for anti-scN antibodies by the one-step test. (K–O) 5 representatives of the 19 positive samples are shown.

    Article Snippet: Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were purchased from SinoBiological (cat. 40588-T62).

    Techniques: Positive Control

    (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.

    Journal: PeerJ

    Article Title: A novel one-step quick assay for detection of SARS-COV2 antibodies across mammalian species

    doi: 10.7717/peerj.11381

    Figure Lengend Snippet: (A) A strategy of direct visualization of antigen-antibody reaction via aggregation by protein A/G/L. Antigen is labeled with GFP. Protein A/G/L cross-links Ig Fc and/or light chain of all antibodies (IgG, IgM, IgA, IgE, and IgD) that bind antigen-GFP to form high fluorescence aggregates. Aggregating fluorescent antigen-antibody complexes simultaneously depletes background fluorescence to achieve a high sensitivity. (B) One-Step assay. Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid proteins were diluted in human serum. Different amount of the rabbit antibodies (100 ng (C), 10 ng (D), 1 ng (E)) was incubated with the scN-GFP fusion proteins for 5 min to examine the detection limit of the one-step test. Blackwhite images show antigen-antibody aggregates, and green fluorescence of the aggregates is shown side by side. Bar: 100 um. Non-specific background of the antigen-antibody aggregates was examined after 5 day incubation of reactions at 4 °C. (F) A pre-pandemic human serum was used as a negative control. (G) A positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein.

    Article Snippet: Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid protein (cat. 40588-T62; SinoBiological, Beijing, China) were diluted in human serum to a concentration of 100 ng/ul, 10 ng/ul, 1 ng/ul, respectively.

    Techniques: Labeling, Fluorescence, Incubation, Negative Control, Positive Control

    (A) The positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein. The negative controls are 4 representative samples (SDBB1-4 (B–E)) from the 50 pre-pandemic human serum samples from San Diego Blood Bank (SDBB). Patient Group A has 20 SARS-CoV2 patient sera deemed positive (either IgG or IgM positive) by LFIA conducted by RayBiotech. All of the 20 patient samples are positive for anti-scN antibodies by the one-step test. (F–J) 5 representatives of the 20 positive samples are shown. Patient Group B has 20 SARS-CoV2 patient serum samples deemed negative (both IgG and IgM are negative) by LFIA conducted by RayBiotech. A total of 19 out of the 20 LFIA negative samples are positive for anti-scN antibodies by the one-step test. (K–O) 5 representatives of the 19 positive samples are shown.

    Journal: PeerJ

    Article Title: A novel one-step quick assay for detection of SARS-COV2 antibodies across mammalian species

    doi: 10.7717/peerj.11381

    Figure Lengend Snippet: (A) The positive control was human serum containing 100 ng of the rabbit antibodies against SARS-CoV2 N nucleocapsid protein. The negative controls are 4 representative samples (SDBB1-4 (B–E)) from the 50 pre-pandemic human serum samples from San Diego Blood Bank (SDBB). Patient Group A has 20 SARS-CoV2 patient sera deemed positive (either IgG or IgM positive) by LFIA conducted by RayBiotech. All of the 20 patient samples are positive for anti-scN antibodies by the one-step test. (F–J) 5 representatives of the 20 positive samples are shown. Patient Group B has 20 SARS-CoV2 patient serum samples deemed negative (both IgG and IgM are negative) by LFIA conducted by RayBiotech. A total of 19 out of the 20 LFIA negative samples are positive for anti-scN antibodies by the one-step test. (K–O) 5 representatives of the 19 positive samples are shown.

    Article Snippet: Rabbit polyclonal antibodies against SARS-CoV2 N nucleocapsid protein (cat. 40588-T62; SinoBiological, Beijing, China) were diluted in human serum to a concentration of 100 ng/ul, 10 ng/ul, 1 ng/ul, respectively.

    Techniques: Positive Control

    Distribution of  SARS-CoV2  antigen in Brain. 4 brains were analyzed at 6dpi. + <++ <+++ Represents Relative density of antigen presence. - No antigen detected. (+) Represents presence of antigen in some samples only. AON-Anterior Olfactory Nucleus. Neuroanatomical Reference: ALLEN Brain Atlas. http://atlas.brain-map.org/atlas?atlas=2#atlas=2&plate=100883770&structure=168&x=7797.5&y=4023.9999997615814&zoom=−3&resolution=10.47&z=5 .

    Journal: Nature

    Article Title: COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice

    doi: 10.1038/s41586-020-2943-z

    Figure Lengend Snippet: Distribution of SARS-CoV2 antigen in Brain. 4 brains were analyzed at 6dpi. + <++ <+++ Represents Relative density of antigen presence. - No antigen detected. (+) Represents presence of antigen in some samples only. AON-Anterior Olfactory Nucleus. Neuroanatomical Reference: ALLEN Brain Atlas. http://atlas.brain-map.org/atlas?atlas=2#atlas=2&plate=100883770&structure=168&x=7797.5&y=4023.9999997615814&zoom=−3&resolution=10.47&z=5 .

    Article Snippet: For SARS-CoV-2 antigen detection, slides were incubated with blocking reagent (10% normal goat serum x 30 minutes) followed by rabbit monoclonal antibody against SARS-CoV2 N protein (1:20,000 dilution x 60 minutes, #40143-R019, Sino Biological US Inc., Wayne, PA, USA), then incubated with Rabbit Envision (Dako) and diaminobenzidine (Dako) as chromogen.

    Techniques: